Big pharma chiefs join forces for emissions reductions

They are partnering through a taskforce launched at COP26 last year, which aims to tackle emissions across patient care, clinical trials and supply chains

GSK to transition North American fleet to 100% EVs by 2030

It is part of the pharmaceutical company’s commitment to the EV100 initiative and is partnering with ARI and Enel X to deliver the project

COP26: GSK becomes Principal Partner for climate change summit

The pharmaceutical company is the ninth Principal Partner that will support the delivery of a successful and ambitious COP26, driving action on climate, nature and health targets in support of the summit’s ambitions

GSK commits to producing a billion recyclable toothpaste tubes by 2025

It is partnering with two global packaging suppliers to launch the fully recyclable toothpaste tubes across its specialist and science-based oral health brands, which includes Sensodyne, parodontax and Aquafresh

Advil aims to reduce plastics in 80m bottles by 20%

The ‘first-of-its-kind’ material that will be used is expected to reduce the amount of plastics by nearly 500,000 pounds